Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

EAPH's Multi-National Pharmaceutical Partnership Agreement to be announced this Quarter!

"This approval will support and is expected to add value to on-going formal negotiations with several multi-national pharmaceutical companies, initiated in late 2015 and early 2016. These multi-national pharmaceutical companies are world-wide leaders in providing innovative products in Women's Health and are striving to grow the Latin American segment of their operations by adding VagiSan to their product offerings. The formidable Sales & Marketing strengths of these multinational companies bodes well for the sales potential for VagiSan and the other Women's Health products, AmnioSense and Gynofit, which are also in active discussions with these potential partners.

Easton and BMV each expect negotiations to be finalized over the next quarter, with all three products now registered in Mexico, and sales expected to begin QI 2017, for one or more products consisting of Gynofit, AmnioSense and VagiSan. Once launched, these products are expected to reach several million dollars in sales within two years of launch."